Home Cytokinetics, Inc. (CYTK) Downgraded to Hold at Zacks Investment Research
 

Keywords :   


Cytokinetics, Inc. (CYTK) Downgraded to Hold at Zacks Investment Research

2016-01-05 05:44:42| Biotech - Topix.net

According to Zacks, "Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology and mechanics of muscle performance, the company is developing small molecule drug candidates engineered to increase muscle function and contractility.

Tags: research hold investment downgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 14A
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Atlantic Tropical Weather Outlook
02.07Eastern North Pacific Tropical Weather Outlook
02.07Murdoch Netflix rival to launch in UK
02.07Hurricane Beryl Forecast Discussion Number 14
02.07Hurricane Beryl Graphics
More »